MPG.eBooks - Search Results

1

Modulating Cytokines as Treatment for Autoimmune Diseases and Cancer

by Mortier, Erwan
Published 2020

Frontiers Media SA

Subjects: “...inhibitor...”

Read Now

2

C1 esterase inhibitor for prophylaxis against hereditary angioedema attacks : a review of the clinical effectiveness, cost-effectiveness, and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Complement C1 Inhibitor Protein / therapeutic use...”

Read Now

3

C1 esterase inhibitor for prophylaxis against hereditary angioedema attacks : a review of the clinical effectiveness, cost-effectiveness, and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Complement C1 Inhibitor Protein / therapeutic use...”

Read Now

4

Inhibiting PARP as a Strategic Target in Cancer

by Kristin Zorn
Published 2016

Frontiers Media SA

Subjects: “...PARP inhibitor...”

Read Now

5

Dendritic Cell-based Immunotherapy in Solid and Haematologic Tumors

by Dal Col, Jessica
Published 2020

Frontiers Media SA

Subjects: “...immune checkpoint inhibitor...”

Read Now

6

Second Line Treatment of Non-Small Cell Lung Cancer: Clinical; Pathological and Molecular Aspects of Novel Promising Drugs

by Umberto Malapelle
Published 2017

Frontiers Media SA

Subjects: “...Tyrosine Kinase Inhibitor...”

Read Now

7

Advances in Head and Neck Cancer Immunology and Immunotherapy

by Abu-Eid, Rasha
Published 2019

Frontiers Media SA

Subjects: “...Immune check point inhibitor...”

Read Now

8

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...

Published 2018

CADTH

Subjects: “...HIV Integrase Inhibitors / therapeutic use...”

Read Now

9

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...

Published 2018

CADTH

Subjects: “...HIV Integrase Inhibitors / therapeutic use...”

Read Now

10

Clinical review report: Dolutegravir/Rilpivirine (Juluca) : (ViiV healthcare)

Published 2018

CADTH

Subjects: “...HIV Integrase Inhibitors / adverse effects...”

Read Now

11

Clinical review report: Dolutegravir/Rilpivirine (Juluca) : (ViiV healthcare)

Published 2018

CADTH

Subjects: “...HIV Integrase Inhibitors / adverse effects...”

Read Now

12

Future research needs for angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), or direct renin inhibitors (DRIs) for treating hypertension...

by Powers, Benjamin J.
Published 2012

Agency for Healthcare Research and Quality

Subjects: “...Renin / antagonists & inhibitors...”

Read Now

13

Future research needs for angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), or direct renin inhibitors (DRIs) for treating hypertension...

by Powers, Benjamin J.
Published 2012

Agency for Healthcare Research and Quality

Subjects: “...Renin / antagonists & inhibitors...”

Read Now

14

Drug class review on newer antiplatelet agents : final report update 1

by Dailey, Janet H.
Published 2007

Oregon Health & Science University, Evidence-Based Practice Center

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Read Now

15

Drug class review on newer antiplatelet agents : final report update 1

by Dailey, Janet H.
Published 2007

Oregon Health & Science University, Evidence-Based Practice Center

Subjects: “...Platelet Aggregation Inhibitors / therapeutic use...”

Read Now

16

Clinical applications of mifepristone (RU 486) and other antiprogestins : assessing the science and recommending a research agenda

by Donaldson, Molla S.
Published 1993

National Academy Press

Subjects: “...Progesterone / antagonists & inhibitors...”

Read Now

17

Dual antiplatelet therapy following percutaneous coronary intervention: A review of the clinical impact of treatment duration

by Wells, George A.
Published 2017

CADTH

Subjects: “...Platelet Aggregation Inhibitors / adverse effects...”

Read Now

18

Glecaprevir / pibrentasvir (Maviret) (AbbVie corporation)

Published 2018

CADTH

Subjects: “...Protease Inhibitors / adverse effects...”

Read Now

19

Dual antiplatelet therapy following percutaneous coronary intervention: A review of the clinical impact of treatment duration

by Wells, George A.
Published 2017

CADTH

Subjects: “...Platelet Aggregation Inhibitors / adverse effects...”

Read Now

20

Glecaprevir / pibrentasvir (Maviret) (AbbVie corporation)

Published 2018

CADTH

Subjects: “...Protease Inhibitors / adverse effects...”

Narrow Search